Why respiratory viral resilience matters
Respiratory viruses remain a recurring public-health challenge. The upper and lower airways are key immune interfaces because they are both entry points and active tissue environments.
About TRIUMPH-NK
TRIUMPH-NK studies whether tissue-resident NK-cell biology can help explain, and potentially support, durable respiratory immune resilience.
Why NK cells
Natural killer cells are fast-acting innate immune cells. TRIUMPH-NK focuses on how tissue positioning and memory-like immune states could contribute to broad respiratory resilience.
What TRIUMPH-NK is trying to learn
The project aims to define respiratory NK-cell states, understand the signals linked to durable tissue residency, and evaluate associations with resilience in relevant research models.
ARIA programme context
TRIUMPH-NK is part of ARIA's Sustained Viral Resilience portfolio. The canonical public ARIA project listing is linked throughout this site.
View the ARIA portfolioPublic project timeline
This public timeline shows broad phases only. Internal month-by-month milestones, decision thresholds, budgets, and operational details are not published here.
1
Set-up and platform building
Build the shared project infrastructure, assays, tissue model capacity, and analysis foundations.
2
Discovery and immune-state mapping
Map tissue-resident NK-cell states and identify signals associated with durable immune programmes.
3
Respiratory model testing
Study NK-cell behaviour in relevant lung and nasal tissue contexts at public-safe resolution.
4
Comparative resilience and safety evaluation
Evaluate whether candidate immune states are associated with respiratory viral resilience while tracking safety-relevant signals.